VR
VRTX•United States
Need professional-grade analysis? Visit stockanalysis.com
$448.62
-1.19%
End of day
Market Cap
$122.53B
P/E Ratio
33.68
Employees
N/A
Dividend Yield
N/A
Price Chart
Risk-Adjusted Performance
Vertex Pharmaceuticals Inc (VRTX) Price Performance
Vertex Pharmaceuticals Inc (VRTX) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $448.62, down 1.19% from the previous close.
Over the past year, VRTX has traded between a low of $366.54 and a high of $509.50. The stock has lost 10.3% over this period. It is currently 11.9% below its 52-week high.
Vertex Pharmaceuticals Inc has a market capitalization of $122.53B, with a price-to-earnings ratio of 33.68.
Company Info
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $9.87B
- EBITDA
- $4.71B
- Profit Margin
- 31.35%
- EPS (TTM)
- 14.05
- Book Value
- 68.20
Technical Indicators
- 52 Week High
- $510.77
- 52 Week Low
- $362.50
- 50 Day MA
- $455.29
- 200 Day MA
- $436.26
- Beta
- 0.32
Valuation
- Trailing P/E
- 33.68
- Forward P/E
- N/A
- Price/Sales
- 10.45
- Price/Book
- 6.89
- Enterprise Value
- $114.93B